Learn more about the activities of the clinicians and researchers in the Department of Psychiatry.
September 26-27, 2024
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. The Conference will be held virtually over the course of two days: Thursday, September 26th and Friday, September 27th, 2024.
Attend the 4th Annual Conference on Precision Psychiatry
October 24, 2024
Perinatal Psychiatry: Treatment During Pregnancy and the Postpartum will focus on the diagnosis and treatment of psychiatric disorders in women across pregnancy and the postpartum. Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy, pregnancy planning, and the postpartum. Exposure to psychotropic medications and the consequence of untreated psychiatric disorders must be considered when treating pregnant women, those who may become pregnant during treatment, and those who are breastfeeding. Up to date and comprehensive knowledge is required to help patients make collaborative and individualized treatment decisions. A strong understanding of the literature pertaining to the reproductive safety of medications is imperative to factoring in potential risks and benefits of medication, and context is particularly critical in putting risks into perspective. Focused material will be presented regarding specialized psychotherapies utilized during pregnancy and the postpartum, as well as an overview of embryology and obstetrics informing a broad range of care modalities.
Attend the Perinatal Psychiatry conference
October 24-27, 2024
We invite you to join us at the Westin Copley Place in Boston for our annual Psychopharmacology conference. This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.
In every session, our faculty share data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.
Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.
Attend the psychopharmacology conference
November 15-16, 2024
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
Attend the 4th Annual Conference on Psychedelics and Psychedelic Medicine
February 17-19, 2025
Attend this conference on substance use disorders to hear the latest research and find guidance that enhances your care for patients.
Substance use disorders are complex and have a huge impact on patients, families and communities They challenge even experienced health care professionals to stay current with evolving guidelines. And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more. That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.
Attend the Substance Use Disorders conference
March 14-16, 2025
Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These areas include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes. That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize your assessment, treatment, and management of child and adolescent patients with psychiatric conditions.
U.S. News & World Report rates Mass General Psychiatry the top in the nation.
We provide care for patients of any age throughout the lifespan.
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
In this large-scale comparative effectiveness trial, researchers demonstrated the equivalence of delivering early palliative care via video versus in-person visits on quality of life in patients with advanced lung cancer.
The Mass General Addiction Recovery Management Service (ARMS) addresses gaming, gambling and problematic digital technology use in young adults.
In a double-blind, randomized, cross-over study of adults who use cannabis regularly, researchers from Massachusetts General Hospital assessed participants’ brain activity under the influence of THC (the main psychoactive component in cannabis) versus placebo.
Advanced meditation and related experiences offer new possibilities for improving mental health and well-being.
Study finds that altered states of consciousness associated with yoga, meditation, mindfulness, and other practices are common, and mostly positive or even transformative, but that for some people, they can be linked to suffering.
Early intervention is critical to prevent progression of CB-PTSD, a disorder that may carry serious health consequences for as many as 8M women a year worldwide.
Neuroscience Advances in Motion is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in psychiatry, neurology and neurosurgery.
